$TTNP TITAN PHARMACEUTICALS INC Insider Trading
Get free email notifications about insider trading in TITAN PHARMACEUTICALS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in TITAN PHARMACEUTICALS INC. Insider overview, share value development, latest insider transactions and email notifications about new events in TITAN PHARMACEUTICALS INC for free.
CIK Number: 0000910267
IRS Number: 943171940
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Trading Symbol: TTNP
Company Address: 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO 94080
Phone number: 6502444990
Market Capitalization: $81.61M
Prev close: $3.95
Average Daily Volume: 92,319
Days Low: $3.65
Year Low: $3.05
Year High: $8.74
TITAN PHARMACEUTICALS INC Latest Insider Transactions
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Feb 11 2021 | TTNP | TITAN PHARMACEUTIC ... | Beebe Katherine | President and COO | Option Exercise | A | 4.02 | 150,000 | 603,000 | 150,000 | |
Feb 11 2021 | TTNP | TITAN PHARMACEUTIC ... | Akers Joseph A | Director | Option Exercise | A | 4.02 | 25,000 | 100,500 | 25,000 | |
Feb 11 2021 | TTNP | TITAN PHARMACEUTIC ... | MACFARLANE M DAVID | Director | Option Exercise | A | 4.02 | 25,000 | 100,500 | 25,000 | |
Feb 11 2021 | TTNP | TITAN PHARMACEUTIC ... | MCNAB JAMES R | Director | Option Exercise | A | 4.02 | 25,000 | 100,500 | 25,000 | |
Feb 11 2021 | TTNP | TITAN PHARMACEUTIC ... | Rubin Marc | Executive Chairman | Option Exercise | A | 4.02 | 150,000 | 603,000 | 150,000 | |
Jun 07 2019 | TTNP | TITAN PHARMACEUTIC ... | Hallberg Dane | See Remarks | Option Exercise | A | 1.50 | 80,000 | 120,000 | 80,000 | |
Apr 03 2019 | TTNP | TITAN PHARMACEUTIC ... | Rubin Marc | Executive Chairman | Option Exercise | A | 1.75 | 200,000 | 350,000 | 200,000 | |
Apr 03 2019 | TTNP | TITAN PHARMACEUTIC ... | BHONSLE SUNIL | President and CEO | Option Exercise | A | 1.75 | 200,000 | 350,000 | 200,000 | |
Oct 22 2018 | TTNP | TITAN PHARMACEUTIC ... | Recli Federico Seghi | Director | Buy | P | 0.00 | 200,000 | 0 | 800,845 | 600.8 K to 800.8 K (+33.29 %) |
Sep 26 2018 | TTNP | TITAN PHARMACEUTIC ... | Recli Federico Seghi | Director | Buy | P | 0.00 | 500,000 | 0 | 600,845 | 100.8 K to 600.8 K (+495.81 %) |
Sep 25 2018 | TTNP | TITAN PHARMACEUTIC ... | MACFARLANE M DAVID | Director | Option Exercise | A | 0.25 | 80,000 | 20,000 | 80,000 | |
Sep 25 2018 | TTNP | TITAN PHARMACEUTIC ... | MACFARLANE M DAVID | Director | Buy | P | 0.25 | 80,000 | 20,000 | 102,275 | 22.3 K to 102.3 K (+359.15 %) |
Sep 25 2018 | TTNP | TITAN PHARMACEUTIC ... | BHONSLE SUNIL | See Remarks | Option Exercise | A | 0.25 | 300,000 | 75,000 | 300,000 | |
Sep 25 2018 | TTNP | TITAN PHARMACEUTIC ... | BHONSLE SUNIL | See Remarks | Buy | P | 0.25 | 300,000 | 75,000 | 435,578 | 135.6 K to 435.6 K (+221.27 %) |
Sep 25 2018 | TTNP | TITAN PHARMACEUTIC ... | MCNAB JAMES R | Director | Option Exercise | A | 0.25 | 200,000 | 50,000 | 200,000 |